IBDEI16N ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,20112,1,3,0)
 ;;=3^Malig Neop Bronchus/Lung,Unspec Part
 ;;^UTILITY(U,$J,358.3,20112,1,4,0)
 ;;=4^C34.90
 ;;^UTILITY(U,$J,358.3,20112,2)
 ;;=^5000966
 ;;^UTILITY(U,$J,358.3,20113,0)
 ;;=C65.9^^84^929^150
 ;;^UTILITY(U,$J,358.3,20113,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20113,1,3,0)
 ;;=3^Malig Neop Renal Pelvis,Unspec
 ;;^UTILITY(U,$J,358.3,20113,1,4,0)
 ;;=4^C65.9
 ;;^UTILITY(U,$J,358.3,20113,2)
 ;;=^5001253
 ;;^UTILITY(U,$J,358.3,20114,0)
 ;;=C50.912^^84^929^131
 ;;^UTILITY(U,$J,358.3,20114,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20114,1,3,0)
 ;;=3^Malig Neop Left Female Breast,Unspec Site
 ;;^UTILITY(U,$J,358.3,20114,1,4,0)
 ;;=4^C50.912
 ;;^UTILITY(U,$J,358.3,20114,2)
 ;;=^5001196
 ;;^UTILITY(U,$J,358.3,20115,0)
 ;;=C50.911^^84^929^153
 ;;^UTILITY(U,$J,358.3,20115,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20115,1,3,0)
 ;;=3^Malig Neop Right Female Breast,Unspec Site
 ;;^UTILITY(U,$J,358.3,20115,1,4,0)
 ;;=4^C50.911
 ;;^UTILITY(U,$J,358.3,20115,2)
 ;;=^5001195
 ;;^UTILITY(U,$J,358.3,20116,0)
 ;;=C50.919^^84^929^123
 ;;^UTILITY(U,$J,358.3,20116,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20116,1,3,0)
 ;;=3^Malig Neop Female Breast,Unspec Site
 ;;^UTILITY(U,$J,358.3,20116,1,4,0)
 ;;=4^C50.919
 ;;^UTILITY(U,$J,358.3,20116,2)
 ;;=^5001197
 ;;^UTILITY(U,$J,358.3,20117,0)
 ;;=C62.90^^84^929^161
 ;;^UTILITY(U,$J,358.3,20117,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20117,1,3,0)
 ;;=3^Malig Neop Testis,Unspec
 ;;^UTILITY(U,$J,358.3,20117,1,4,0)
 ;;=4^C62.90
 ;;^UTILITY(U,$J,358.3,20117,2)
 ;;=^5001236
 ;;^UTILITY(U,$J,358.3,20118,0)
 ;;=D03.9^^84^929^165
 ;;^UTILITY(U,$J,358.3,20118,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20118,1,3,0)
 ;;=3^Melanoma in Situ,Unspec
 ;;^UTILITY(U,$J,358.3,20118,1,4,0)
 ;;=4^D03.9
 ;;^UTILITY(U,$J,358.3,20118,2)
 ;;=^5001908
 ;;^UTILITY(U,$J,358.3,20119,0)
 ;;=C45.0^^84^929^166
 ;;^UTILITY(U,$J,358.3,20119,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20119,1,3,0)
 ;;=3^Mesothelioma of Pleura
 ;;^UTILITY(U,$J,358.3,20119,1,4,0)
 ;;=4^C45.0
 ;;^UTILITY(U,$J,358.3,20119,2)
 ;;=^5001095
 ;;^UTILITY(U,$J,358.3,20120,0)
 ;;=C90.01^^84^929^168
 ;;^UTILITY(U,$J,358.3,20120,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20120,1,3,0)
 ;;=3^Multiple Myeloma,In Remission
 ;;^UTILITY(U,$J,358.3,20120,1,4,0)
 ;;=4^C90.01
 ;;^UTILITY(U,$J,358.3,20120,2)
 ;;=^267515
 ;;^UTILITY(U,$J,358.3,20121,0)
 ;;=C90.00^^84^929^169
 ;;^UTILITY(U,$J,358.3,20121,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20121,1,3,0)
 ;;=3^Multiple Myeloma,Not in Remission
 ;;^UTILITY(U,$J,358.3,20121,1,4,0)
 ;;=4^C90.00
 ;;^UTILITY(U,$J,358.3,20121,2)
 ;;=^5001752
 ;;^UTILITY(U,$J,358.3,20122,0)
 ;;=C94.6^^84^929^170
 ;;^UTILITY(U,$J,358.3,20122,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20122,1,3,0)
 ;;=3^Myelodysplastic Disease NEC
 ;;^UTILITY(U,$J,358.3,20122,1,4,0)
 ;;=4^C94.6
 ;;^UTILITY(U,$J,358.3,20122,2)
 ;;=^5001846
 ;;^UTILITY(U,$J,358.3,20123,0)
 ;;=D61.82^^84^929^171
 ;;^UTILITY(U,$J,358.3,20123,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20123,1,3,0)
 ;;=3^Myelophthisis
 ;;^UTILITY(U,$J,358.3,20123,1,4,0)
 ;;=4^D61.82
 ;;^UTILITY(U,$J,358.3,20123,2)
 ;;=^334037
 ;;^UTILITY(U,$J,358.3,20124,0)
 ;;=D47.9^^84^929^172
 ;;^UTILITY(U,$J,358.3,20124,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20124,1,3,0)
 ;;=3^Neop Lymphoid,Hematopoietic & Related Tissue,Uncertain Behavior
 ;;^UTILITY(U,$J,358.3,20124,1,4,0)
 ;;=4^D47.9
 ;;^UTILITY(U,$J,358.3,20124,2)
 ;;=^5002260
 ;;^UTILITY(U,$J,358.3,20125,0)
 ;;=D53.9^^84^929^176
 ;;^UTILITY(U,$J,358.3,20125,1,0)
 ;;=^358.31IA^4^2
